To start page
2012-2-23 +/-% Buy Sell Latest Volume Turnover (SEK)
NVP -7.04% 18.50 18.60 18.50 65 845 1 231 429.10
  • Home
  • About NeuroVive
  • Research & Development
  • Investors
  • Contact
Investors
  • Contacts
  • News releases
  • In the News
  • Stock
  • Shareholder reports
  • Corporate governance
  • Analyst coverage
  • Presentations
  • Ownership
  • Calendar
  • Financial calendar
Start / Investors / Shareholder reports

Shareholder reports

2011

Q1 January - March Svensk flagga / Q1 January - March
Q2 January - June Svensk flagga   / Q2 January - June
Q3 January - September Svensk flagga / Q3 January - September

2010

Annual Report Svensk flagga
Year-End Report Svensk flagga / Year-End Report
Q1 January - March Svensk flagga
Q2 January - June Svensk flagga
Q3 January - September Svensk flagga
Prospectus
Svensk flagga
Teaser Svensk flagga

2009 Svensk flagga

Annual Report
Year-End Report
Q1 January - March
Q2 January - June
Q3 January - September

more...

Eleonor Åsander Frostner

Responsible editor Eleonor Åsander Frostner eleonor.asander@neurovive.com Last updated: 2011-12-06

Year-End report 2010

Year-End Report 2010

Q2 2011

Q3 January - September 2011

  • About NeuroVive
    • In brief
    • Board of Directors
    • Management Team
    • Advisory Board
    • Corporate Governance
    • Partnerships
    • Career
  • Research & Development
    • Project overview
    • Research overview
    • Our products
    • Relevant publications
  • Investors
    • Contacts
    • News releases
    • In the News
    • Stock
    • Shareholder reports
    • Corporate governance
    • Analyst coverage
    • Presentations
    • Ownership
    • Calendar
    • Financial calendar
  • Contact
    • Investors
    • Business development
    • Research
    • How to find us

NeuroVive Pharmaceutical AB (publ), Biomedical Center, BMC D10, SE-221 84 Lund, Sweden

Tel: +46 (0)46 288 01 10 | Fax: +46 (0)46 888 83 48 | info@neurovive.com | Legal & Privacy